BRWA
LXRX icon

B. Riley Wealth Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

B. Riley Wealth Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,429
Closed -$9K – 1374
2014
Q4 		$9K Buy
+1,429
New +$11.5K ﹤0.01% 2924

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

B. Riley Wealth Advisors's LXRX Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2015, closing a stake of 1,429 shares — an estimated $9K sold.

B. Riley Wealth Advisors first reported a position in LXRX in Q4 2014 and held it in 1 quarter. The position peaked at $9K in Q4 2014. 119 funds tracked by Wall St. Rank hold LXRX as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Lexicon Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,429 Lexicon Pharmaceuticals shares in Q1 2015, an estimated $9K.
  • B. Riley Wealth Advisors first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Lexicon Pharmaceuticals position peaked at $9K in Q4 2014.
  • 119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.